home / stock / bbio / bbio short
Short Information | BridgeBio Pharma Inc. (NYSE:BBIO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 95,126 |
Total Actual Volume | 7,264,925 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 4,756 |
Average Short Percentage | 1.31% |
Is there a BBIO Short Squeeze or Breakout about to happen?
See the BBIO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $35.05 | $34.65 | $35.07 | $33.77 | 249,717 | 1,044 | 0.42% |
02-11-2020 | $36.83 | $34.84 | $37.5999 | $34.57 | 452,375 | 14,333 | 3.17% |
02-10-2020 | $35.04 | $36.23 | $36.26 | $34.951 | 290,193 | 2,153 | 0.74% |
02-07-2020 | $35.39 | $34.995 | $35.90 | $34.85 | 398,885 | 7,960 | 2% |
02-06-2020 | $35.46 | $35.40 | $35.97 | $34.79 | 458,023 | 3,569 | 0.78% |
02-05-2020 | $34.93 | $35.00 | $35.49 | $34.48 | 326,803 | 2,196 | 0.67% |
02-04-2020 | $35.00 | $34.50 | $35.20 | $34.18 | 455,467 | 12,013 | 2.64% |
02-03-2020 | $34.63 | $34.81 | $35.35 | $34.20 | 335,303 | 852 | 0.25% |
01-31-2020 | $34.77 | $34.49 | $34.94 | $33.25 | 281,971 | 1,952 | 0.69% |
01-30-2020 | $34.03 | $34.93 | $35.4676 | $33.01 | 293,618 | 1,947 | 0.66% |
01-29-2020 | $34.26 | $34.24 | $35.08 | $33.23 | 256,799 | 10,682 | 4.16% |
01-28-2020 | $35.00 | $34.26 | $35.057 | $33.67 | 267,492 | 1,759 | 0.66% |
01-27-2020 | $34.00 | $34.80 | $35.21 | $34.00 | 326,593 | 4,195 | 1.28% |
01-24-2020 | $34.45 | $34.13 | $35.13 | $33.87 | 500,033 | 6,261 | 1.25% |
01-23-2020 | $33.95 | $34.39 | $35.00 | $33.01 | 260,858 | 1,826 | 0.7% |
01-22-2020 | $32.38 | $34.16 | $34.90 | $32.2401 | 332,289 | 9,812 | 2.95% |
01-21-2020 | $34.21 | $32.23 | $34.45 | $31.28 | 594,825 | 3,299 | 0.55% |
01-17-2020 | $35.33 | $34.40 | $35.63 | $34.00 | 234,945 | 2,478 | 1.05% |
01-16-2020 | $34.90 | $35.00 | $35.50 | $34.47 | 593,560 | 2,552 | 0.43% |
01-15-2020 | $34.67 | $34.51 | $35.09 | $34.00 | 355,176 | 4,243 | 1.19% |
News, Short Squeeze, Breakout and More Instantly...
2024-06-20 00:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- BridgeBio has surpassed its interim analysis enrollment target for its Phase 3 FORTIFY study of BBP-418 in individuals living with LGMD2I/R9, with top-line results from the interim analysis expected in 2025 - Recent Type C interactions with U.S. Food and Drug Administration (FDA) focu...
PALO ALTO, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that Neil Kumar, Ph.D., founder and CEO...